Chandler, ARIZONA1 Active Studies

Clostridioides Difficile Infection Clinical Trials in Chandler, ARIZONA

Find 1 actively recruiting clostridioides difficile infection clinical trials in Chandler, ARIZONA. Connect with local research sites and explore new treatment options.

1
Active Trials
1
Sponsors
852
Enrolling

Recruiting Clostridioides Difficile Infection Studies in Chandler

About Clostridioides Difficile Infection Clinical Trials in Chandler

Clostridioides difficile infection is a bacterial infection that causes inflammation of the colon, often following antibiotic use. It can cause severe diarrhea and life-threatening colitis. Treatment includes specific antibiotics, and fecal microbiota transplantation for recurrent cases.

There are currently 1 clostridioides difficile infection clinical trials recruiting participants in Chandler, ARIZONA. These studies are seeking a combined 852 participants. Research is being sponsored by Vedanta Biosciences, Inc.. Clinical trial participation is free and participants receive study-related medical care at no cost.

Clostridioides Difficile Infection Clinical Trials in Chandler — FAQ

Are there clostridioides difficile infection clinical trials in Chandler?

Yes, there are 1 clostridioides difficile infection clinical trials currently recruiting in Chandler, ARIZONA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Chandler?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Chandler research site will contact you about next steps.

Are clinical trials in Chandler free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Chandler studies also compensate for your time and travel.

What clostridioides difficile infection treatments are being tested?

The 1 active trials in Chandler are testing new therapies including novel drugs, biologics, and treatment approaches for clostridioides difficile infection.

Data updated March 2, 2026 from ClinicalTrials.gov